Sign in

    Benjamin Shaver

    Research Analyst at Deutsche Bank AG

    No publicly available information could be found confirming Benjamin Shaver as an analyst or in any professional role at Deutsche Bank AG. There are no records detailing his current job title, specialization, company coverage, performance metrics, career timeline, or professional credentials on major platforms such as LinkedIn, financial industry databases, or regulatory listings. As a result, key details about his coverage universe, investment performance, or professional recognitions also remain unavailable.

    Benjamin Shaver's questions to Pediatrix Medical Group (MD) leadership

    Benjamin Shaver's questions to Pediatrix Medical Group (MD) leadership • Q4 2024

    Question

    Benjamin Shaver asked for a breakdown of the Q4 pricing strength, the timing of the EBITDA benefit from portfolio restructuring, and the company's plans for capital allocation given its strong cash position.

    Answer

    CFO Kasandra Rossi noted that hospital admin fees were just under a third of the pricing component and that about one-third of the $30M restructuring EBITDA benefit was realized in 2024, with the rest to come in 2025. CEO Mark Ordan stated that a strong balance sheet is a priority in turbulent times and that the board will determine the best use of cash as the year progresses.

    Ask Fintool Equity Research AI